ENABLE Biotech aims to partner with companies from research to clinical stage to address specific challenges of manufacturing advanced therapies.

We Offer:

CMC EXPERTISE
Team with specific expertise and capabilities in the field of CGT manufacturing, ensuring a smooth transition of manufacturing processes
Sponsors don’t need to worry about completing CMC sections for regulatory approvals or considering the future clinical development requirements

FLEXIBILITY
Transparent collaboration on developing manufacturing and QA process, providing flexibility for future in-house production or tech transfer
We focus on pre-clinical to Phase IIa production, but sponsors will be equipped to make the transition to a phase-adapted CDMO or their own facility when the time is right

SPEED
Available capacity in SwissMedic accredited GMP facility R&D and manufacturing suites, avoiding delays to First in Human
Easy shipment between patients in Europe and the manufacturing facility

AFFORDABILITY
Attractive costs for affordable therapies through use of existing facility
Minimizing costs without compromising quality or timelines through efficient resource utilization
Custom fee-for-service pricing models

Contact us to learn more about how ENABLE BioTech can become YOUR next-generation CDMO. 

contact@enablebiotech.com

ENABLE BIOTECH

Org chart

Teams

Offices

ENABLE BIOTECH

Org chart

Teams

Offices

Related companies